Top

Published in:

01-11-2013 | Original Article

Lower limb lymphedema in gynecological cancer survivors—effect on daily life functioning

Authors: Gail Dunberger, Helene Lindquist, Ann-Charlotte Waldenström, Tommy Nyberg, Gunnar Steineck, Elisabeth Åvall-Lundqvist

Published in: Supportive Care in Cancer | Issue 11/2013

Abstract

Purpose

Lower limb lymphedema (LLL) is a common condition after pelvic cancer treatment but few studies have evaluated its effect on the quality of life and its consequences on daily life activities among gynecological cancer survivors.

Methods

We identified a cohort of 789 eligible women, treated with pelvic radiotherapy alone or as part of combined treatment of gynecological cancer, from 1991 to 2003 at two departments of gynecological oncology in Sweden. As a preparatory study, we conducted in-depth interviews with gynecological cancer survivors and constructed a study-specific questionnaire which we validated face-to-face. The questionnaire covered physical symptoms originating in the pelvis, demographic, psychological, and quality of life factors. In relation to the lymph system, 19 questions were asked.

Results

Six hundred sixteen (78 %) gynecological cancer survivors answered the questionnaire and participated in the study. Thirty-six percent (218/606) of the cancer survivors reported LLL. Overall quality of life was significantly lower among cancer survivors with LLL. They were also less satisfied with their sleep, more worried about recurrence of cancer, and more likely to interpret symptoms from the body as recurrence. Cancer survivors reported that LLL kept them from physical activity (45 %) and house work (29 %) and affected their ability to partake in social activities (27 %) or to meet friends (20 %).

Conclusion

Lower limb lymphedema has a negative impact on quality of life among gynecological cancer survivors, affecting sleep and daily life activities, yet only a few seek professional help.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef

Dunberger G, Lind H, Steineck G, Waldenström AC, Nyberg T, Al-Abany M, Nyberg U, Åvall-Lundqvist E (2010) Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. Eur J Cancer 46:606–615PubMedCrossRef

Nout RA, van de Poll-Franse LV, Lybeert ML, Warlam-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras B, van Putten WL, Creutzberg CL (2011) Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol 29:1692–1700PubMedCrossRef

Dunberger G, Lind H, Steineck G, Waldenström AC, Onelöv E, Åvall-Lundqvist E (2011) Loose stools lead to fecal incontinence among gynecological cancer survivors. Acta Oncol 50:233–242PubMedCrossRef

Bergmark K, Åvall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G (1999) Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 340:1383–1389PubMedCrossRef

Waldenström AC et al (2011) Pain and mean absorbed dose to the pubic bone after radiotherapy among gynecological cancer survivors. Int J Radiat Oncol Biol Phys 80:1171–1180PubMedCrossRef

Dunberger G et al (2010) Fecal incontinence affecting quality of life and social functioning among long-term gynecological cancer survivors. Int J Gynecol Cancer 20:449–460PubMedCrossRef

Beesley V, Janda M, Eakin E, Obermair A, Battistutta D (2007) Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 109:2607–2614PubMedCrossRef

Bergmark K, Åvall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G (2006) Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer 16:1130–1139PubMedCrossRef

10.

Finnane A, Hayes SC, Obermair A, Janda M (2011) Quality of life of women with lower-limb lymphedema following gynecological cancer. Expert Rev Pharmacoecon Outcome Res 11:287–297CrossRef

11.

Ryan M, Stainton MC, Jaconelli C, Watts S, MacKenzie P, Mansberg T (2003) The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncol Nurs Forum 30:417–423PubMedCrossRef

12.

Kim JH, Choi JH, Ki EY, Lee SJ, Yoon JH, Lee KH, Park TC, Park JS, Bae SN, Hur SY (2012) Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer. Int J Gynecol Cancer 22:686–691PubMedCrossRef

13.

Badger C, Preston N, Seers K, Mortimer P (2004) Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev 4, CD003141PubMed

14.

Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR (2008) Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol 26:5689–5696PubMedCrossRef

15.

Pyszel A, Malyszczak K, Pyszel K, Andrzejak R, Szuba A (2006) Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 39:185–192PubMed

16.

Lind H, Waldenström AC, Dunberger G, Al-Abany M, Alevronta E, Johansson KA, Olsson C, Nyberg T, Wilderäng U, Steineck G et al (2011) Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Br J Cancer 105:737–745PubMedCrossRef

17.

Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, Bill-Axelson A (2012) Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol 12:891–899CrossRef

18.

Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA (2002) Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 20:4242–4248PubMedCrossRef

19.

Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT (2002) Lymphedema and quality of life in survivors of early stage breast cancer. Arch Surg 137:1253–1257PubMedCrossRef

20.

Beesley V, Eakin E, Steginga S, Aitken J, Dunn J, Battistutta D (2008) Unmet needs of gynaecological cancer survivors: implications for developing community support services. Psychooncology 17:392–400PubMedCrossRef

21.

Lockwood-Rayermann S (2007) Lymphedema in gynecologic cancer survivors: an area for exploration? Cancer Nurs 30:E11–E18PubMedCrossRef

22.

Horne J (2011) Obesity and short sleep: unlikely bedfellows? Obes Rev ISSN: Off J Int Assoc Study Obes 12:e84–e94CrossRef

23.

Dahl AA, Nesvold IL, Reinertsen KV, Fosså SD (2011) Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations. Sleep medicine 12:584–590PubMedCrossRef

24.

Szuba A, Rockson SG (1997) Lymphedema: anatomy, physiology and pathogenesis. Vascular medicine 2:321–326PubMed

25.

Ohba Y, Todo Y, Kobayashi N, Kaneuchi M, Watari H, Takeda M, Sudo S, Kudo M, Kato H, Sakuragi N (2011) Risk factors for lower-limb lymphedema after surgery for cervical cancer. Int J Clin Oncol/Jpn Soc Clin Oncol 16:238–243CrossRef

26.

Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16:1959–1972PubMedCrossRef

27.

Towers A, Carnevale FA, Baker ME (2008) The psychosocial effects of cancer-related lymphedema. Journal of palliative care 24:134–143PubMed

28.

Finnane A, Liu Y, Battistutta D, Janda M, Hayes SC (2011) Lymphedema after breast or gynecological cancer: use and effectiveness of mainstream and complementary therapies. J altern Complement Med 17:867–869PubMedCrossRef

29.

Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA: J Am Med Assoc 304:2699–2705CrossRef

Title: Lower limb lymphedema in gynecological cancer survivors—effect on daily life functioning
Authors: Gail Dunberger
Helene Lindquist
Ann-Charlotte Waldenström
Tommy Nyberg
Gunnar Steineck
Elisabeth Åvall-Lundqvist
Publication date: 01-11-2013
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 11/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-013-1879-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2013

Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer

Systematic review of natural agents for the management of oral mucositis in cancer patients

Assessing quality of life in long-term cancer survivors: a review of available tools

Challenges of accrual in supportive care trials in pediatric oncology

Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX

Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics

Keynote webinar | Spotlight on antibody–drug conjugates in cancer